Literature DB >> 12379912

Microglia in brain tumors.

Manuel B Graeber1, Bernd W Scheithauer2, Georg W Kreutzberg3.   

Abstract

Microglia have long been ignored by neurooncologists. This has changed with the realization that microglial cells not only occur within and around brain tumors but also contribute significantly to the actual tumor mass, notably in astrocytic gliomas. In addition, it has been speculated that microglia could play a role in the defense against neoplasms of the nervous system. However, the biological success of these tumors, i.e., their highly malignant behavior, indicates that natural microglial defense mechanisms do not function properly in astrocytomas. In fact, there is evidence that microglial behavior is controlled by tumor cells, supporting their growth and infiltration. This unexpected "Achilles heel" of microglial immune defense illustrates the risk of generalizing on the basis of a single aspect of microglial biology. Microglia are highly plastic cells, capable of exerting cytotoxic functions under conditions of CNS infections, but not necessarily during glioma progression. Thus, the suggestion that microglial activation through stimulation by cytokines (e.g., interferon-gamma) will benefit patients with brain tumors could prove fatally wrong. Therapeutic recruitment of microglia to treat such diffusely infiltrative brain tumors as astrocytic gliomas must be considered premature. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12379912     DOI: 10.1002/glia.10147

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   8.073


  139 in total

1.  A much convenient and economical method to harvest a great number of microglia.

Authors:  Kun Qin; Ye-Hai Li; Ge Tian; Wei-Wei Xu; Peng Li; Run Zhang; Zheng-Yang Li; Xiao-Dan Jiang
Journal:  Cell Mol Neurobiol       Date:  2011-07-16       Impact factor: 5.046

Review 2.  Brain Tumor Microenvironment and Host State: Implications for Immunotherapy.

Authors:  William Tomaszewski; Luis Sanchez-Perez; Thomas F Gajewski; John H Sampson
Journal:  Clin Cancer Res       Date:  2019-02-25       Impact factor: 12.531

Review 3.  Microglial phenotype and adaptation.

Authors:  B J L Eggen; D Raj; U-K Hanisch; H W G M Boddeke
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

Review 4.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurosci       Date:  2011-08-03       Impact factor: 34.870

Review 5.  Immune response and immunotherapy to Cryptococcus infections.

Authors:  Qing Zhou; William J Murphy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

6.  Carboxyethylpyrroles: From Hypothesis to the Discovery of Biologically Active Natural Products.

Authors:  Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-11-02       Impact factor: 3.739

Review 7.  Using neurofibromatosis-1 to better understand and treat pediatric low-grade glioma.

Authors:  David H Gutmann
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

8.  Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival.

Authors:  Rainer Glass; Michael Synowitz; Golo Kronenberg; Joo-Hee Walzlein; Darko S Markovic; Li-Ping Wang; Daniela Gast; Jürgen Kiwit; Gerd Kempermann; Helmut Kettenmann
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

Review 9.  Interleukins in glioblastoma pathophysiology: implications for therapy.

Authors:  Y T Yeung; K L McDonald; T Grewal; L Munoz
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

Review 10.  Targeting astrocytomas and invading immune cells with cannabinoids: a promising therapeutic avenue.

Authors:  Eiron Cudaback; Nephi Stella
Journal:  Mol Neurobiol       Date:  2007-07-03       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.